Search Results

There are 26165 results for: content related to: Special Situations: Management of Elderly Patients and Chronic Lymphocytic Leukemia in Transformation

  1. You have free access to this content
    Guidelines on the diagnosis and management of chronic lymphocytic leukaemia

    British Journal of Haematology

    Volume 125, Issue 3, May 2004, Pages: 294–317, D. Oscier, C. Fegan, P. Hillmen, T. Illidge, S. Johnson, P. Maguire, E. Matutes and D. Milligan

    Version of Record online : 1 APR 2004, DOI: 10.1111/j.1365-2141.2004.04898.x

  2. You have free access to this content
    A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53

    British Journal of Haematology

    Volume 167, Issue 2, October 2014, Pages: 149–161, Polina Shindiapina, Jennifer R. Brown and Alexey V. Danilov

    Version of Record online : 20 JUL 2014, DOI: 10.1111/bjh.13042

  3. You have free access to this content
    Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment

    American Journal of Hematology

    Volume 90, Issue 5, May 2015, Pages: 446–460, Michael Hallek

    Version of Record online : 23 APR 2015, DOI: 10.1002/ajh.23979

  4. You have free access to this content
    Richter syndrome: molecular insights and clinical perspectives

    Hematological Oncology

    Volume 27, Issue 1, March 2009, Pages: 1–10, Davide Rossi and Gianluca Gaidano

    Version of Record online : 10 FEB 2009, DOI: 10.1002/hon.880

  5. You have free access to this content
    The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications

    British Journal of Haematology

    Volume 169, Issue 1, April 2015, Pages: 14–31, Jonathan C. Strefford

    Version of Record online : 11 DEC 2014, DOI: 10.1111/bjh.13254

  6. Alemtuzumab (MabCampath)

    Handbook of Therapeutic Antibodies

    Thomas Elter, Andreas Engert, Michael Hallek, Pages: 733–777, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch28

  7. Treatment of chronic lymphoid leukemias with monoclonal antibodies: current place and perspectives

    Drug Development Research

    Volume 69, Issue 7, November 2008, Pages: 373–387, Tadeusz Robak

    Version of Record online : 23 DEC 2008, DOI: 10.1002/ddr.20269

  8. B-chronic lymphocytic leukemia: practical aspects

    Hematological Oncology

    Volume 20, Issue 3, September 2002, Pages: 103–146, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos, Maria N. Dimopoulou, Marina P. Siakantaris, Flora N. Kontopidou and Maria K. Angelopoulou

    Version of Record online : 26 APR 2002, DOI: 10.1002/hon.696

  9. You have free access to this content
    Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients

    British Journal of Haematology

    Volume 170, Issue 1, July 2015, Pages: 40–49, Anders Österborg, William G. Wierda, Jiří Mayer, Georg Hess, Peter Hillmen, Johannes Schetelig, Anna Schuh, Lukáš Smolej, Christian Beck, Brigitte Dreyfus, Andrzej Hellman, Piotr Kozlowski, Michael Pfreundschuh, Rita Rizzi, Martin Spacek, Jennifer L. Phillips, Ira V. Gupta, Vanessa Williams, Roxanne C. Jewell, Noelia Nebot, Steen Lisby and Martin J. S. Dyer

    Version of Record online : 30 MAR 2015, DOI: 10.1111/bjh.13380

  10. You have free access to this content
    The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy – the MD Anderson Cancer Center experience

    British Journal of Haematology

    Volume 171, Issue 2, October 2015, Pages: 281–284, Philip A. Thompson, Uri Rozovski, Michael J. Keating, Francesco Stingo, Susan C. Smith, William G. Wierda, Lorenzo Falchi, Susan M. O'Brien, Zeev Estrov, Jan A. Burger and Alessandra Ferrajoli

    Version of Record online : 30 MAR 2015, DOI: 10.1111/bjh.13377

  11. You have free access to this content
    A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia

    British Journal of Haematology

    Volume 167, Issue 4, November 2014, Pages: 466–477, Farrukh T. Awan, Peter Hillmen, Andrzej Hellmann, Tadeusz Robak, Steven G. Hughes, Denise Trone, Megan Shannon, Ian W. Flinn, John C. Byrd and on behalf of the LUCID trial investigators

    Version of Record online : 8 AUG 2014, DOI: 10.1111/bjh.13061

  12. You have free access to this content
    Revisiting the role of cladribine in acute myeloid leukemia: An improvement on past accomplishments or more old news?

    American Journal of Hematology

    Volume 90, Issue 1, January 2015, Pages: 62–72, Craig W. Freyer, Neha Gupta, Meir Wetzler and Eunice S. Wang

    Version of Record online : 24 OCT 2014, DOI: 10.1002/ajh.23862

  13. Therapy of Chronic Lymphocytic Leukemia: Front-Line and Salvage

    Leukemias: Principles and Practice of Therapy

    Valentin Goede, Barbara Eichhorst, Michael Hallek, Pages: 308–314, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch25

  14. Rituximab (Rituxan)

    Handbook of Therapeutic Antibodies

    Stefan Dübel, Pages: 1033–1108, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch39

  15. You have free access to this content
    Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study

    British Journal of Haematology

    Volume 153, Issue 3, May 2011, Pages: 351–357, Emilio Iannitto, Fortunato Morabito, Salvatrice Mancuso, Massimo Gentile, Antonella Montanini, Accursio Augello, Velia Bongarzoni, Alfonso D’Arco, Nicola Di Renzo, Rita Fazzi, Giovanni Franco, Roberto Marasca, Antonino Mulè, Maurizio Musso, Pellegrino Musto, Elsa Pennese, Andrea Piccin, Delia Rota-Scalabrini, Giuseppe Visani and Luigi Rigacci

    Version of Record online : 4 MAR 2011, DOI: 10.1111/j.1365-2141.2011.08597.x

  16. You have free access to this content
    Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas

    British Journal of Haematology

    Volume 169, Issue 6, June 2015, Pages: 814–823, Felipe Samaniego, Fredrick Hagemeister, Jorge E. Romaguera, Michelle A. Fanale, Barbara Pro, Peter McLaughlin, M. Alma Rodriguez, Sattva S. Neelapu, Luis Fayad, Anas Younes, Lei Feng, Zuzana Berkova, Tamer Khashab, Lalit Sehgal, Francisco Vega-Vasquez and Larry W. Kwak

    Version of Record online : 31 MAR 2015, DOI: 10.1111/bjh.13367

  17. You have free access to this content
    Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia

    British Journal of Haematology

    Volume 155, Issue 2, October 2011, Pages: 182–189, Pamela S. Becker, Hagop M. Kantarjian, Frederick R. Appelbaum, Stephen H. Petersdorf, Barry Storer, Sherry Pierce, Jianqin Shan, Paul C. Hendrie, John M. Pagel, Andrei R. Shustov, Derek L. Stirewalt, Stephan Faderl, Elizabeth Harrington and Elihu H. Estey

    Version of Record online : 18 AUG 2011, DOI: 10.1111/j.1365-2141.2011.08831.x

  18. You have free access to this content
    EBV negative Richter's syndrome from a coexistent clone after salvage treatment with alemtuzumab in a CLL patient

    American Journal of Hematology

    Volume 81, Issue 9, September 2006, Pages: 706–712, Ann Janssens, Mario Berth, Pascale De Paepe, Bruno Verhasselt, Nadine Van Roy, Lucien Noens, Jan Philippé and Fritz Offner

    Version of Record online : 12 JUL 2006, DOI: 10.1002/ajh.20712

  19. You have free access to this content
    Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemia

    Cancer

    Volume 121, Issue 21, November 1, 2015, Pages: 3869–3876, Nicholas J. Short, Michael J. Keating, William G. Wierda, Stefan Faderl, Alessandra Ferrajoli, Zeev Estrov, Susan C. Smith and Susan M. O'Brien

    Version of Record online : 28 JUL 2015, DOI: 10.1002/cncr.29605

  20. You have free access to this content
    Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma)

    British Journal of Haematology

    Volume 153, Issue 4, May 2011, Pages: 451–485, Claire E. Dearden, Rod Johnson, Ruth Pettengell, Stephen Devereux, Kate Cwynarski, Sean Whittaker, Andrew McMillan and British Committee for Standards in Haematology

    Version of Record online : 11 APR 2011, DOI: 10.1111/j.1365-2141.2011.08651.x